IL6 and COVID-19: In COVID-19, interleukin-6 level is elevated (15, 16), and due to its mediating role in the lung and destruction of pulmonary alveoli (14), side effects such as drop in blood oxygen saturation level and coughing are expected, which is consistent with the results of the present study.